<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bmjour</journal-id><journal-title-group><journal-title xml:lang="ru">Байкальский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Baikal Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-0715</issn><publisher><publisher-name>Irkutsk State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.57256/2949-0715-2023-1-25-32</article-id><article-id custom-type="elpub" pub-id-type="custom">bmjour-34</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original articles</subject></subj-group></article-categories><title-group><article-title>ОСОБЕННОСТИ ЭНДОКРИННОГО ПРОФИЛЯ ПРИ ГИПЕРТРОФИЧЕСКИХ И КЕЛОИДНЫХ РУБЦАХ КОЖИ</article-title><trans-title-group xml:lang="en"><trans-title>FEATURES OF ENDOCRINE PROFILE IN HYPERTROPHIC AND KELOID SCARS OF SKIN</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7759-1078</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кобец</surname><given-names>Максим Владимирович</given-names></name><name name-style="western" xml:lang="en"><surname>Kobets</surname><given-names>Maxim Vladimirovich</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аспирант кафедры патологической физиологии ФГБОУ ВО ИГМУ Минздрава России, г. Иркутск</p></bio><email xlink:type="simple">kobetsmv@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО ИГМУ Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk Regional Clinical Hospital, Irkutsk, Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>10</day><month>03</month><year>2023</year></pub-date><volume>2</volume><issue>1</issue><fpage>25</fpage><lpage>32</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кобец М.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Кобец М.В.</copyright-holder><copyright-holder xml:lang="en">Kobets M.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.bmjour.ru/jour/article/view/34">https://www.bmjour.ru/jour/article/view/34</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование. Учитывая роль гормонов в регуляции процессов формирования и ремоделирования рубцов, целесообразно исследовать особенности гормонального профиля при патологических рубцах, что даст возможность повысить эффективность диагностики типа рубца и сформировать патогенетическую основу лечения гипертрофических и келоидных рубцов.</p></sec><sec><title>Цель работы</title><p>Цель работы: выявление особенностей гормонального профиля при гипертрофических и келоидных рубцах.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Выполнена оценка клинического состояния рубцов и исследован гормональный профиль (10 гормонов) у 90 женщин с гипертрофическими, келоидными и нормотрофическими рубцами (контроль). Кровь брали до лечения на 5–7 сутки менструального цикла. Результаты обработаны методами непараметрической статистики (Me (Q25-Q75), U-критерий при p&lt;0,05). Корреляционные связи между гормонами определялись методом множественной регрессии при коэффициенте детерминации R2&gt;0,7.</p></sec><sec><title>Результаты</title><p>Результаты. У всех пациенток с патологическими рубцами выявлено снижение уровня кортизола. Для гипертрофических рубцов характерно повышение концентрации фолликулостимулирующего гормона, снижение концентрации эстрадиола и тестостерона. У пациенток с келоидами повышена концентрация гормона роста, снижен уровень пролактина, лютеинизирующего гормона. Регрессионный анализ показал, что при нормотрофических рубцах взаимозависимость гормонов выражена максимально, тогда как при патологических рубцах показатели гормонального профиля имеют 1-2 корреляции. При этом изменяются качественный состав и направленность взаимосвязей.</p></sec><sec><title>Заключение</title><p>Заключение. Для патологического рубцевания характерно снижение уровня кортизола в крови, которое при келоидных рубцах более выражено в сочетании со сниженным пролактином. При гипертрофических рубцах выявлены ослабление гормональных взаимодействий и дисбаланс в системе половых гормонов, а при келоидных рубцах – высокая концентрация гормона роста и устойчивое взаимодействие стероидогенеза с ослабленной способностью к адаптации.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Given the role of hormones in the regulation of scar formation and remodeling processes, it is advisable to study the features of the hormonal profile in conditions of pathological scars. This will improve the efficiency of diagnosing of scar type and form a pathogenetic basis for the treatment of hypertrophic and keloid scars.</p></sec><sec><title>Aim</title><p>Aim. To identify the features of the hormonal profile in conditions of hypertrophic and keloid scars.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The clinical state of the scars and the hormonal profile (10 hormones) were studied in 90 women with hypertrophic, keloid and normotrophic scars (control). Blood was taken before treatment on the 5th–7th day of the menstrual cycle. The results were processed by non-parametric statistics (Me (Q25-Q75), U-test at p&lt;0.05). Correlations between hormones were determined by the method of multiple regression at the coefficient of determination R2&gt;0.7.</p></sec><sec><title>Results</title><p>Results. All patients with pathological scars showed a decrease in cortisol levels. Hypertrophic scars are characterized by an increase in the concentration of follicle-stimulating hormone, a decrease in the concentration of estradiol and testosterone. In patients with keloids, the concentration of growth hormone is increased, the levels of prolactin, luteinizing hormone are reduced. Regression analysis showed that the interdependence of hormones is maximally expressed in conditions of normotrophic scars, while hormones had 1-2 correlations in conditions of pathological scars. At the same time, the qualitative composition and direction of interrelations have changed.</p></sec><sec><title>Conclusion</title><p>Conclusion. Pathological scarring is characterized by a decrease in the level of cortisol in the blood, which is expressed in patients with keloid scars in combination with reduced prolactin. A weakening of hormonal interactions and an imbalance in the system of sex hormones were revealed in conditions of hypertrophic scars. and the increased production of growth hormone in combination with a stable interaction between steroidogenesis and a weakened adaptive ability took place in conditions of keloid scars.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>гипертрофические рубцы</kwd><kwd>келоидные рубцы</kwd><kwd>патологическое рубцевание</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypertrophic scars</kwd><kwd>keloid scars</kwd><kwd>pathological scarring</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">ФГБОУ ВО ИГМУ Минздрава России</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Huang C., Ogawa R. Systemic factors that shape cutaneous pathological scarring. FASEB J. 2020;34(10):13171-13184. https://doi.org/10.1096/fj.202001157R</mixed-citation><mixed-citation xml:lang="en">Huang C., Ogawa R. Systemic factors that shape cutaneous pathological scarring. FASEB J. 2020;34(10):13171-13184. https://doi.org/10.1096/fj.202001157R</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Шафранов В.В., Борхунова Е.Н., Таганов А.В. и др. Келоидные рубцы: этиология, клиническая, морфологическая, физикальная диагностика и лечение СВЧ – криогенным методом. М.;2003:192 [Shafranov V.V., Borkhunova E.N., Taganov A.V. et al. Keloidnye rubcy: etiologiya, klinicheskaya, morfologicheskaya, fizikal'naya diagnostika i lechenie SVCH – kriogennym metodom. Moscow;2003:192 (In Russian)]</mixed-citation><mixed-citation xml:lang="en">Shafranov V.V., Borkhunova E.N., Taganov A.V. et al. Keloidnye rubcy: etiologiya, klinicheskaya, morfologicheskaya, fizikal'naya diagnostika i lechenie SVCH – kriogennym metodom. Moscow;2003:192 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Baryza M.J., Baryza G.A. The Vancouver Scar Scale: an administration tool and its interrater reliability. J Burn Care Rehabil. 1995;16(5):535-538. https://doi.org/10.1097/00004630-199509000-00013</mixed-citation><mixed-citation xml:lang="en">Baryza M.J., Baryza G.A. The Vancouver Scar Scale: an administration tool and its interrater reliability. J Burn Care Rehabil. 1995;16(5):535-538. https://doi.org/10.1097/00004630-199509000-00013</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Комисаренко В.П., Минченко А.Г., Тронько Н.Д. Молекулярные механизмы действия стероидных гормонов. Киев: «Здоровье»;1986:192 [Komisarenko V.P., Minchenko A.G., Tron'ko N.D. Molekulyarnye mekhanizmy dejstviya steroidnyh gormonov: Kiev: «Zdorov'e»;1986:192 (In Russian)]</mixed-citation><mixed-citation xml:lang="en">Komisarenko V.P., Minchenko A.G., Tron'ko N.D. Molekulyarnye mekhanizmy dejstviya steroidnyh gormonov: Kiev: «Zdorov'e»;1986:192 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Reish R.G., Eriksson E. Scar treatments: preclinical and clinical studies. J Am Coll Surg. 2008;206(4):719-730. https://doi.org/10.1016/j.jamcollsurg.2007.11.022</mixed-citation><mixed-citation xml:lang="en">Reish R.G., Eriksson E. Scar treatments: preclinical and clinical studies. J Am Coll Surg. 2008;206(4):719-730. https://doi.org/10.1016/j.jamcollsurg.2007.11.022</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gilliver S.C., Ashworth J.J., Mills S.J. et al. Androgens modulate the inflammatory response during acute wound healing. J Cell Sci. 2006;119(Pt 4):722-732. https://doi.org/10.1242/jcs.02786</mixed-citation><mixed-citation xml:lang="en">Gilliver S.C., Ashworth J.J., Mills S.J. et al. Androgens modulate the inflammatory response during acute wound healing. J Cell Sci. 2006;119(Pt 4):722-732. https://doi.org/10.1242/jcs.02786</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Horng H.C., Chang W.H., Yeh C.C. et al. Estrogen Effects on Wound Healing. Int J Mol Sci. 2017;18(11):2325. https://doi.org/10.3390/ijms18112325</mixed-citation><mixed-citation xml:lang="en">Horng H.C., Chang W.H., Yeh C.C. et al. Estrogen Effects on Wound Healing. Int J Mol Sci. 2017;18(11):2325. https://doi.org/10.3390/ijms18112325</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Scacchi M., Valassi E., Pincelli A.I. et al. Increased lipid peroxidation in adult GH-deficient patients: effects of short-term GH administration. J Endocrinol Invest. 2006;29(10):899-904. https://doi.org/10.1007/BF03349194</mixed-citation><mixed-citation xml:lang="en">Scacchi M., Valassi E., Pincelli A.I. et al. Increased lipid peroxidation in adult GH-deficient patients: effects of short-term GH administration. J Endocrinol Invest. 2006;29(10):899-904. https://doi.org/10.1007/BF03349194</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Messias de Lima C.F., de Araújo Vieira L.F., de Carvalho Wanderley LA, de Souza Ferro JN, Smaniotto S. Topical Growth Hormone Accelerates Wound Healing in Mice. Wounds. 2017;29(12):387-392. URL: https://pubmed.ncbi.nlm.nih.gov/28976342/ [accessed: 05.12.2022]</mixed-citation><mixed-citation xml:lang="en">Messias de Lima C.F., de Araújo Vieira L.F., de Carvalho Wanderley LA, de Souza Ferro JN, Smaniotto S. Topical Growth Hormone Accelerates Wound Healing in Mice. Wounds. 2017;29(12):387-392. URL: https://pubmed.ncbi.nlm.nih.gov/28976342/ [accessed: 05.12.2022]</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Thorey I.S., Hinz B., Hoeflich A. et al. Transgenic mice reveal novel activities of growth hormone in wound repair, angiogenesis, and myofibroblast differentiation. J Biol Chem. 2004;279(25):26674-26684. https://doi.org/10.1074/jbc.M311467200</mixed-citation><mixed-citation xml:lang="en">Thorey I.S., Hinz B., Hoeflich A. et al. Transgenic mice reveal novel activities of growth hormone in wound repair, angiogenesis, and myofibroblast differentiation. J Biol Chem. 2004;279(25):26674-26684. https://doi.org/10.1074/jbc.M311467200</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lee Y.R., Oshita Y., Tsuboi R., Ogawa H. Combination of insulin-like growth factor (IGF)-I and IGF-binding protein-1 promotes fibroblast-embedded collagen gel contraction. Endocrinology. 1996;137(12):5278-5283. https://doi.org/10.1210/endo.137.12.8940346</mixed-citation><mixed-citation xml:lang="en">Lee Y.R., Oshita Y., Tsuboi R., Ogawa H. Combination of insulin-like growth factor (IGF)-I and IGF-binding protein-1 promotes fibroblast-embedded collagen gel contraction. Endocrinology. 1996;137(12):5278-5283. https://doi.org/10.1210/endo.137.12.8940346</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hu Z.C., Tang B., Guo D. et al. Expression of insulin-like growth factor-1 receptor in keloid and hypertrophic scar. Clin Exp Dermatol. 2014;39(7):822-828. https://doi.org/10.1111/ced.12407</mixed-citation><mixed-citation xml:lang="en">Hu Z.C., Tang B., Guo D. et al. Expression of insulin-like growth factor-1 receptor in keloid and hypertrophic scar. Clin Exp Dermatol. 2014;39(7):822-828. https://doi.org/10.1111/ced.12407</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Levine S., Muneyyirci-Delale O. Stress-Induced Hyperprolactinemia: Pathophysiology and Clinical Approach. Obstet Gynecol Int. 2018;2018:9253083. https://doi.org/10.1155/2018/9253083</mixed-citation><mixed-citation xml:lang="en">Levine S., Muneyyirci-Delale O. Stress-Induced Hyperprolactinemia: Pathophysiology and Clinical Approach. Obstet Gynecol Int. 2018;2018:9253083. https://doi.org/10.1155/2018/9253083</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Duffy D.M., Ko C., Jo M., Brannstrom M., Curry T.E. Ovulation: Parallels With Inflammatory Processes. Endocr Rev. 2019;40(2):369-416. https://doi.org/10.1210/er.2018-00075</mixed-citation><mixed-citation xml:lang="en">Duffy D.M., Ko C., Jo M., Brannstrom M., Curry T.E. Ovulation: Parallels With Inflammatory Processes. Endocr Rev. 2019;40(2):369-416. https://doi.org/10.1210/er.2018-00075</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mazziotti G., Giustina A. Glucocorticoids and the regulation of growth hormone secretion. Nat Rev Endocrinol. 2013;9(5):265-276. https://doi.org/10.1038/nrendo.2013.5</mixed-citation><mixed-citation xml:lang="en">Mazziotti G., Giustina A. Glucocorticoids and the regulation of growth hormone secretion. Nat Rev Endocrinol. 2013;9(5):265-276. https://doi.org/10.1038/nrendo.2013.5</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Agha A., Monson J.P. Modulation of glucocorticoid metabolism by the growth hormone - IGF-1 axis. Clin Endocrinol (Oxf). 2007;66(4):459-465. https://doi.org/10.1111/j.1365-2265.2007.02763.x</mixed-citation><mixed-citation xml:lang="en">Agha A., Monson J.P. Modulation of glucocorticoid metabolism by the growth hormone - IGF-1 axis. Clin Endocrinol (Oxf). 2007;66(4):459-465. https://doi.org/10.1111/j.1365-2265.2007.02763.x</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Cook D.M. Growth hormone and estrogen: a clinician's approach. J Pediatr Endocrinol Metab. 2004;17 Suppl 4:1273-1276. URL: https://pubmed.ncbi.nlm.nih.gov/15506073/ [accessed: 05.12.2022]</mixed-citation><mixed-citation xml:lang="en">Cook D.M. Growth hormone and estrogen: a clinician's approach. J Pediatr Endocrinol Metab. 2004;17 Suppl 4:1273-1276. URL: https://pubmed.ncbi.nlm.nih.gov/15506073/ [accessed: 05.12.2022]</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Sun L., Gao Z., Luo L., Tan H., Zhang G. Estrogen affects cell growth and IGF-1 receptor expression in renal cell carcinoma. Onco Targets Ther. 2018;11:5873-5878. https://doi.org/10.2147/OTT.S172149</mixed-citation><mixed-citation xml:lang="en">Sun L., Gao Z., Luo L., Tan H., Zhang G. Estrogen affects cell growth and IGF-1 receptor expression in renal cell carcinoma. Onco Targets Ther. 2018;11:5873-5878. https://doi.org/10.2147/OTT.S172149</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Brownlee K.K., Moore A.W., Hackney A.C. Relationship between circulating cortisol and testosterone: influence of physical exercise. J Sports Sci Med. 2005;4(1):76-83. URL: https://pubmed.ncbi.nlm.nih.gov/24431964/ [accessed: 05.12.2022]</mixed-citation><mixed-citation xml:lang="en">Brownlee K.K., Moore A.W., Hackney A.C. Relationship between circulating cortisol and testosterone: influence of physical exercise. J Sports Sci Med. 2005;4(1):76-83. URL: https://pubmed.ncbi.nlm.nih.gov/24431964/ [accessed: 05.12.2022]</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
